Following a particularly severe flu season in 2024–2025, with millions of cases and tens of thousands of deaths, vaccination efforts are more critical than ever. FluMist Home removes key barriers, such as scheduling conflicts, travel limitations, and needle phobia, giving patients greater control and ease in protecting themselves and their families. 

FluMist is a needle-free live-attenuated influenza vaccine first approved for clinical use in 2003. In September 2024, the FDA expanded its approval to allow self- or caregiver-administration at home for individuals aged 2–49, making it the first flu vaccine that doesn’t require a healthcare provider to administer.

Now, FluMist Home is available in 34 U.S. states (including Michigan) via online ordering.

How It Works

• Eligibility: Available for children ages 2–17 when administered by a caregiver, and adults ages 18–49
• Ordering Process:
  1. Complete an online medical screening at FluMist.com.
  2. A licensed provider reviews and approves the prescription.
  3. The package—insulated and cold-stored—arrives at home, complete with instructions, disposal envelope, and optional video or pharmacist support. 
• Cost: The vaccine itself is generally covered by insurance, with $8.99 shipping and processing fee. For uninsured users, coupons may lower the cost to around $30.
• Administration: Spritz one dose into each nostril. A caregiver should assist children under 18.

Effectiveness

Medical experts affirm that FluMist Home performs similarly to traditional flu shots for eligible groups. However, certain populations should avoid it, including those who are:

• Over 50
• Immunocompromised
• Pregnant
• Taking aspirin (for children)
• Experiencing nasal congestion

For more information, click here.